Even the best medicine has side effects. For years, dairy producers have been selectively breeding their herds to encourage milk production. New insights have confirmed, though, that such efforts to satisfy society's demand for milk, cheese ...
Tags: Agriculture, Food
The U.S. Food and Drug Administration approved on Friday a first-of-its-kind blood test that can scan a child's genetic code and spot possible genetic explanations for developmental delays or intellectual disabilities. The test can ...
A genetic variant occurring in a significant number of people with heart disease appears to raise the odds for heart attack or death by 38 percent, a new study suggests. This "stress reaction gene," which Duke University scientists ...
Tags: heart disease, genetic variant, stress reaction gene, stress hormone
Nine of 10 women do not need and should not receive genetic testing to see if they are at risk for breast or ovarian cancer, an influential panel of health experts announced Monday. The U.S. Preventive Services Task Force (USPSTF) ...
Tags: breast cancer, ovarian cancer, women health, genetic testing
A "misfire" is the way Eric Topol, MD, describes 23andMe's recent regulatory tussle with the FDA, which resulted in the Silicon Valley-based company halting sales for now of its health-related genetic test analysis. Speaking with MPMN ...
Tags: 23andme, FDA, regulatory tussle
Under pressure from the FDA, 23andMe says it will stop selling health-related genetic test analysis until it has resolved its dispute with the federal regulatory agency. "We remain firmly committed to fulfilling our long-term mission to ...
More than a week after the FDA told 23andMe to stop marketing its Personal Genomic Service tests, the Mountain View, CA–based company says it is complying. "23andMe halted all marketing last week in accordance with the FDA’s ...
Posted in Testing Services by Chris Newmarker on November 25, 2013 The FDA is telling 23andMe to stop marketing its Personal Genomic Service tests. The FDA’s move is but another sign that the regulator is increasingly concerned ...
Tags: 23andMe, DNA, Hit, FDA, warning letter
Diagnostic information services provider Quest Diagnostics has rolled out its new lab-developed genetic test to support the delivery of modified opioid pain-relieving treatment. It effectively tests for variants in all cytochrome P450 ...
Scientists at the Institute of Cancer Research, London, The Royal Marsden NHS Foundation Trust and Queen Mary University of London have developed a new breast cancer test, dubbed as PAM50, to help women avoid unnecessary chemotherapy. The ...
Tags: Breast Cancer, Chemotherapy
Medcan Clinic, a private health care clinic in Canada, has entered into a collaboration agreement with Pathway Genomics. Under the agreement, Pathway Genomics will allow Medcan's patients to use its Personal Genome Test. Using only a ...
Tags: Medcan Clinic, Pathway Genomics, collaboration agreement
National Institutes of Health's National Center For Advancing Translational Sciences has awarded $100,000 small business technology transfer program (STTR) Phase I grant to Transgenomic to develop a genetic test that can detect pancreatic ...
Tags: genetic test, ICE COLD-PCR, genetic information, Pancreatic Cancer Test